PDF4PRO ⚡AMP

Modern search engine that looking for books and documents around the web

Example: quiz answers

Second Generation Antipsychotic Sheet - Magellan Provider

1 2014 2017 Magellan Health, Inc. rev 2/17 Second Generation Antipsychotic Tip Sheet Second Generation Antipsychotic Medications Arpiprazole/Abilify/Abilify Maintena/Aristada Asenapine/Saphris Clozapine/Clozaril/Versacloz Iloperidone/Fanapt Lurasidone/Latuda Olanzapine/Zyprexa/Zyprexa Relprevv Brexpiprazole/Rexulti Cariprazine/Vraylar Paliperidone/Invega/Invega Sustenna/Invega Trinza Quetiapine/Seroquel/Seroquel XR Risperidone/Risperdal/Risperdal Consta Ziprasidone/Geodon Medical Issues Related to Second Generation Antipsychotics Usage in Adultsi,iiSecond- Generation antipsychotics may cause abnormal blood work in adults such as: Elevated serum glucose Elevated serum lipids Increased prolactin levels Conditions experienced may include: Weight gain Increased risk of type 2 diabetes Cardiovascular side effects Increased abdominal girth Diabetic ketoacidosis Sudden death in elderly Monitoring Patients on Second Generation Antipsychotics Medication The American Diabetes Association, the American Psychiatric Association, the American Association of Clinical Endocrinologists, and the North American Association for the Study of Obesity recommend the following screening measures for monitoring patients using Second - Generation Measure Baseline 4 weeks 8 weeks 12 weeks Quarterly Annually Personal/Family History X

effects vary between the different drugs Monitoring can reduce the risk of metabolic side effects Practitioners should base selection of antipsychotic on individual risk factors for each patient. For instance, previous response, side effect profiles, family history, co-morbid

Fullscreen Download
Loading..

Tags:

  Drug, Provider, Antipsychotic, Magellan, Magellan provider

Information

Domain:

Source:

Link to this page:

Please notify us if you found a problem with this document:

Spam in document Broken preview Other abuse

Transcription of Second Generation Antipsychotic Sheet - Magellan Provider

Documents from same domain

Using Correct License-level Modifiers on Your Claims

www.magellanprovider.com

©2005-2018 Magellan Health, Inc. Last reviewed 2/2018 Using Correct License-level Modifiers on Your Claims Magellan organizational providers and individual providers submitting professional (CPT) claims as part of an organization (using the organization’s Taxpayer Identification Number) must submit claims with the license-level modifier that …

  Using, License, Levels, Correct, Using correct license level modifiers on, Modifiers

Coordination of Benefits - Magellan Provider

www.magellanprovider.com

Coordination of Benefits Coordination of Benefits Magellan coordinates benefits with other payers when a member is covered by two or more group health benefit plans.

  Benefits, Provider, Coordination, Magellan, Coordination of benefits, Magellan provider, Coordination of benefits coordination of benefits

2018 Handbook for the National Provider Network

www.magellanprovider.com

National Provider Network Handbook 4—© 2000-2018 Magellan Health, Inc. 11/17 Case Management Member Rights and Responsibilities Magellan Clinical Practice Guidelines

  Network, Practices, Handbook, National, Provider, Handbook for the national provider network

Policy and Standards - Magellan Provider

www.magellanprovider.com

FALSE CLAIMS LAWS AND WHISTLEBLOWER PROTECTIONS Page 1 of 23 —PROPRIETARY Magellan Health policies apply to all subsidiaries and affiliates, including but not limited to Magellan Healthcare, …

  Health, Provider, Claim, Magellan, Magellan provider

Treatment Record Review Tool - Magellan Provider

www.magellanprovider.com

Treatment Record Review Tool This is the standard review tool used for all behavioral health records. Additional indicators may be included based on regulatory and/or customer requirements.

  Review, Treatment, Record, Behavioral, Tool, Provider, Magellan, Magellan provider, Treatment record review tool

Authorization to Use or Disclose Protected Health ...

www.magellanprovider.com

Last Updated: 03/10/07 Authorization to Disclose Protected Health Information to Primary Care Physician Communication between your behavioral health provider(s) and your primary care physician (PCP) is important to make sure all care is complete,

  Health, Information, Authorization, Protected, Disclose, Authorization to use or disclose protected health, Disclose protected health information

Magellan’s Update of its Introduction to the …

www.magellanprovider.com

© 2005-2017 Magellan Health, Inc. This document is the proprietary information of Magellan Health, Inc. and its affiliates. 6/17 Magellan’s Update of its Introduction to the American Psychiatric Association’s Clinical Practice Guideline

  American, Guidelines, Practices, Association, Psychiatric, Practice guidelines, American psychiatric association

Organization & Facility Handbook Supplement

www.magellanprovider.com

Organizational and Facility Provider Handbook Supplement 2—© 2004-2018 Magellan Health, Inc. 11/17 Table of Contents SECTION 1: INTRODUCTION ..... 4

  Supplement, Handbook, Organizational, Handbook supplement

1. HOSPITALIZATION - Hospitalization is the highest …

www.magellanprovider.com

MAGELLAN UNIVERSAL SERVICES LIST - Includes Preferred HIPAA Compliant Codes 3.1 Partial Hospitalization, Psychiatric. Assists individuals who …

  Psychiatric

2018 Handbook for the National Provider Network

www.magellanprovider.com

National Provider Network Handbook 4—© 2000-2018 Magellan Health, Inc. 11/17 Case Management Member Rights and Responsibilities Magellan Clinical Practice Guidelines

  Network, Management, Handbook, National, Provider, Handbook for the national provider network

Related documents

HALDOL - Food and Drug Administration

www.accessdata.fda.gov

Given these considerations, antipsychotic drugs should be prescribed in a manner that is most likely to minimize the occurrence of tardive dyskinesia. Chronic antipsychotic treatment should generally be reserved for patients who suffer from a chronic illness that, 1) is known to respond to antipsychotic drugs, and, 2) for whom alternative,

  Administration, Drug, Food and drug administration, Food, Antipsychotic, Haldol, Antipsychotic drugs

Adverse Effects of Antipsychotic Medications

www.aafp.org

Mar 01, 2010 · Latest Antipsychotic Drugs in Schizophrenia The use of antipsychotic medications entails a difficult trade-off between the benefit of alleviating psychotic symp- toms and the risk of troubling ...

  Drug, Antipsychotic, Antipsychotic drugs

Atypical Antipsychotic Medications: Use in Adults

www.cms.gov

antipsychotic drugs, revealed a risk of death in drug-treated patients of between 1.6 to 1.7 times the risk of death in placebo-treated patients. Over the course of a typical 10-week controlled trial, the rate of death in drug-treated patients was about 4.5%, compared to a …

  Drug, Antipsychotic, Antipsychotic drugs

Guidelines for Antipsychotic Medication Switches

www.psychdb.com

Switching Antipsychotic Drugs Approaches to switching medication vary in the rate of change and extent of any overlap of agents. Pharmacokinetically and pharmacologically the lowest risk strategy for switching is to have a drug free interval. In practice the aim is to avoid additive effects of the agents that

  Drug, Antipsychotic, Antipsychotic drugs

Antipsychotic Monitoring - OHSU

www.ohsu.edu

Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators. Effectiveness of antipsychotic drugs in patients withhronic c schizophrenia. N Engl J Med. 2005;353(12): 1209-1223. 9.orrell C CU, Manu P, Olshanskiy V, et al. Cardiometabolic risk of second-generation antipsychotic medications during first-time

  Drug, Antipsychotic, Ohsu, Antipsychotic drugs

Atypical Antipsychotic Medications: Use in Pediatric Patients

www.cms.gov

has identified issues with the utilization of the atypical antipsychotic, or second-generation . antipsychotic (SGA), drug therapy class. The U.S. Food and Drug Administration (FDA) approves product labeling for prescription drugs. The MIG has identified that some providers may have prescribed atypical

  Drug, Antipsychotic

DRUGS USED IN ICU - Weebly

chestgmcpatiala.weebly.com

•All drugs, infusions and fluids are reviewed and transcribed at least daily. •Drugs should be prescribed according to Unit protocols and guidelines. •Where possible: a) Use drugs that can be measured ... Antipsychotic Management of predisposing & Causative Conditions.

  Drug, Antipsychotic

HIGH DOSE ANTIPSYCHOTIC THERAPY GUIDELINE

www.oxfordhealthformulary.nhs.uk

Calculating antipsychotic dose using the percentage method An antipsychotic dosage ready reckoner3 is the easiest way to calculate antipsychotic dose. It consists of a table of all the currently available antipsychotics which states the equivalent percentage of a dose. A copy can be found on the intranet – click on the picture on the right.

  Antipsychotic

DEPOT ANTIPSYCHOTIC MEDICATION: GUIDELINES FOR …

www.candi.nhs.uk

Oral antipsychotic coverage should therefore be given during the first 3 weeks of treatment. Oral antipsychotic supplementation on a reducing titration is sometimes required for longer (6-8 weeks)2,12. 5.4.6 The depot must be administered every two weeks as the pharmacokinetic profile does not allow for longer intervals. .

  Antipsychotic

Related search queries

HALDOL, Food and Drug Administration, Antipsychotic drugs, Antipsychotic, OHSU, Drugs